Skip to main content
. Author manuscript; available in PMC: 2026 Sep 1.
Published before final editing as: Arthritis Rheumatol. 2026 Jun 4:10.1002/art.70240. doi: 10.1002/art.70240

Table 3:

Epigenetic transcriptional accessibility (ATAC-Seq) differences between various OA and control groups

Cellular subset #ATAC peaks different at P≤0.01 #ATAC peaks different at q≤0.05 #ATAC peaks more accessible in OA Top 5 genes more accessible in OA #ATAC peaks less accessible in OA Top 5 genes less accessible in OA
OA vs. HC
CD8+ memory cells 516 0 n/a n/a n/a n/a
CD4+ regulatory T cells 1174 162 6 ASMT, CCND3, PRAG1, CROCC, PRKX 156 LMNL, CHAF1B, FSIP1, GALNT1, KLF6
Monocytes 1805 346 272 CNYP1, GAB2, ADAMTS4, MDM1, MYH9 74 CHAF1B, BCAS1, IFNGR2, LDHA, SCD
Basophils 50 0 n/a n/a n/a n/a
Plasmablasts 329 3 0 n/a 3 LMNL, AC067752.1, SORL1
Eosinophils 551 0 n/a n/a n/a n/a
MAIT/NKTs 736 3 0 n/a 3 CHAF1B, FGD1, TBKBP1
RP vs. NP
CD4+ central memory cells 387 6 4 PRKY, TXLNGY, EIF1AY, DDX3Y 2 RP11, ZRSR2
CD8+ central memory cells 222 0 n/a n/a n/a n/a
CD8+ terminal memory cells 188 5 5 PRKY, EIF1AY, DDX3Y, TXLNGY, UTY 0 n/a